Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 126.30% institutional investors, 0.79% insiders. Fmr is the largest institutional shareholder, holding 16.07% of JBIO shares. Franklin US Small Cap Value Equity is the top mutual fund, with 3.65% of its assets in Jade Biosciences shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 126.30% | 0.79% | -27.10% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 9.81M | 16.07% | $137.83M |
| Janus henderson group | 3.11M | 9.90% | $43.56M |
| Fairmount funds management | 4.55M | 7.88% | $101.18M |
| Ra capital management | 3.67M | 6.35% | $81.57M |
| Franklin resources | 3.81M | 6.24% | $57.26M |
| Vr adviser | 3.22M | 5.57% | $71.56M |
| Blackrock funding, inc. /de | 3.37M | 5.51% | $47.30M |
| Vanguard group | 2.10M | 5.29% | $32.34M |
| Bellevue group | 3.06M | 5.29% | $67.95M |
| Paradigm biocapital advisors lp | 2.86M | 4.95% | $63.49M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 991.78K | 12.77% | $13.93M |
| Remedium capital partners | 1.81M | 9.28% | $25.40M |
| Fairmount funds management | 4.55M | 6.69% | $101.18M |
| Avidity partners management lp | 1.70M | 6.05% | $37.79M |
| Acorn capital advisors | 986.76K | 5.98% | $21.93M |
| Foresite capital management vi | 886.67K | 3.07% | $19.70M |
| Vr adviser | 3.22M | 2.17% | $71.56M |
| Bellevue group | 3.06M | 1.43% | $67.95M |
| Samsara biocapital | 736.24K | 1.34% | $16.36M |
| Verdad advisers, lp | 56.38K | 1.20% | $1.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M |
| Polar capital | 1.85M | 0.10% | 1.85M |
| Franklin resources | 3.81M | 0.01% | 1.02M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -2.28M |
| Frazier life sciences management | - | - | -1.41M |
| Great point partners | - | - | -964.46K |
| Driehaus capital management | - | - | -635.50K |
| Rtw investments, lp | - | - | -573.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M | $43.56M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M | $63.49M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M | $42.46M |
| Polar capital | 1.85M | 0.10% | 1.85M | $41.04M |
| Blackstone | 435.32K | 0.03% | 435.32K | $9.67M |
Sold Out
| Holder | Change |
|---|---|
| Wealth enhancement trust services | -1.00 |
| Clearstead advisors | -3.00 |
| Principal securities | -5.00 |
| Mai capital management | -6.00 |
| Stone house investment management | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 157 | 27.64% | 72,973,653 | 46.40% | 126 | 1.70% | 115 | 74.24% | 24 | -31.43% |
| Mar 31, 2026 | 62 | -41.51% | 12,616,762 | -73.20% | 40 | 0.28% | 32 | -59.49% | 21 | 61.54% |
| Dec 31, 2025 | 75 | -1.32% | 20,804,363 | -34.20% | 52 | 0.82% | 55 | 77.42% | 10 | -54.55% |
| Sep 30, 2025 | 29 | -59.15% | 6,448,004 | -79.55% | 22 | 0.18% | 9 | -87.14% | 14 | - |
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin US Small Cap Value Equity | 2.32M | 3.65% | 1.83M |
| State Street® SPDR® S&P® Biotech ETF | 1.84M | 2.89% | 48.18K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.70M | 2.79% | 284.01K |
| Vanguard Total Stock Mkt Idx Inv | 1.70M | 2.79% | 284.01K |
| Polar Capital Biotech S Inc | 1.75M | 2.75% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.70M | 2.67% | - |
| Fidelity Growth Compy Commingled Pl S | 1.63M | 2.67% | 242.10K |
| Fidelity Growth Company Fund | 1.19M | 1.87% | - |
| Franklin Small Cap Value A | 1.06M | 1.67% | -566.81K |
| Janus Henderson Hrzn Biotec E2 USD | 963.35K | 1.58% | 215.85K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools